$CMRX Recent News Ebola stock trading volumes should

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CMRX Recent News

Ebola stock trading volumes should raise red flags 3:08 p.m. Oct. 13, 2014 - Wallace Witkowski
CSX leads railroads higher; Fiat debuts in U.S. market 1:02 p.m. Oct. 13, 2014 - Sue Chang
Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Oct. 13, 2014 - The Trading Deck
10 biggest financial-market events of the week 5:16 p.m. Oct. 10, 2014 - Philip van Doorn
Stopping Ebola lacks one crucial thing: money 6:11 a.m. Oct. 9, 2014 - David Weidner
U.S. to start screening for Ebola at five airports 6:25 p.m. Oct. 8, 2014 - Russ Britt
Ebola patient dies in Dallas hospital 12:10 p.m. Oct. 8, 2014 - Russ Britt
Chimerix shares drop after Ebola patient dies 11:37 a.m. Oct. 8, 2014 - Wallace Witkowski
Chimerix shares tumble 15% after Dallas Ebola patient dies 11:34 a.m. Oct. 8, 2014 - Ciara Linnane
Chimerix shares up 5.9% in premarket trade 8:33 a.m. Oct. 8, 2014 - Ciara Linnane
Chimerix Ebola drug shows promise for another ailment 8:30 a.m. Oct. 8, 2014 - Michael Calia
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 8:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Ebola vaccine use likely to be confined, experts say 7:28 a.m. Oct. 8, 2014 - Russ Britt
JP Morgan wasn't the only bank targeted by hackers 2:11 a.m. Oct. 7, 2014 - MarketWatch
Number of companies fighting Ebola grows, one wins fed OK 4:09 p.m. Oct. 6, 2014 - Russ Britt
Ebola patient treated with Chimerix drug, report says 3:51 p.m. Oct. 6, 2014 - Russ Britt
Chimerix continues to surge after decision to help ailing 7-year-old boy 5:28 p.m. March 13, 2014 - Russ Britt
FDA agrees to rapid Chimerix drug test program to help treat dying boy 10:39 a.m. March 12, 2014 - Russ Britt
Chimerix says it's had 'hundreds' of requests for early use of virus drug 2:23 p.m. March 11, 2014 - Russ Britt
Chimerix under pressure to help dying boy with experimental drug 10:51 a.m. March 11, 2014 - Russ Britt


Chimerix to Conduct Clinical Trial of Ebola Drug 39 min ago - The Wall Street Journal Interactive Edition
Chimerix (CMRX) Hits New Lifetime High Today 12:02 p.m. Today - TheStreet.com
Roller coaster ride continues for Ibio 9:09 a.m. Today - Seeking Alpha
Second Dallas Health Worker Headed for Atlanta 8:35 p.m. Oct. 15, 2014 - The Wall Street Journal Interactive Edition
Trade-Ideas: Chimerix (CMRX) Is Today's Post-Market Leader Stock 6:59 p.m. Oct. 15, 2014 - TheStreet.com
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
10 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 15, 2014 - InvestorPlace.com
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha
Ebola Stocks: A Real Portfolio Killer 7:35 a.m. Oct. 13, 2014 - Seeking Alpha
Chimerix Says Will Offer R&D Update on Webcast on Oct. 15th at 4:30 p.m. EDT 7:09 a.m. Oct. 13, 2014 - benzinga.com
Ebola Patient in Nebraska Shows Slight Improvement 4:24 p.m. Oct. 10, 2014 - The Wall Street Journal Interactive Edition
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
'Fast Money' Recap: How to Trade in a Volatile Marketplace 5:00 a.m. Oct. 10, 2014 - TheStreet.com
Chimerix Falls as Ebola Patient on Brincidofovir Dies in US - Analyst Blog 4:30 p.m. Oct. 9, 2014 - Zacks.com
Alpha Pro Tech enjoying the Ebola ride 1:52 p.m. Oct. 9, 2014 - Seeking Alpha
Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear 1:38 p.m. Oct. 9, 2014 - Investors Business Daily
Researchers Aren’t Ruling Out Treatment Used in Dallas Case 10:57 p.m. Oct. 8, 2014 - The Wall Street Journal Interactive Edition
Making Money With Charles Payne: 10/08/14 6:00 p.m. Oct. 8, 2014 - FOXBusiness
Corporate Watch: News Digest 5:34 p.m. Oct. 8, 2014 - The Wall Street Journal Interactive Edition
Why Chimerix (CMRX) Stock Closed Lower Today 4:04 p.m. Oct. 8, 2014 - TheStreet.com


Chimerix Provides Update on Research and Development Progress 11:45 a.m. Today - GlobeNewswire
Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene 9:10 a.m. Oct. 15, 2014 - PR Newswire - PRF
Chimerix to Webcast R&D Update on October 15th 8:02 a.m. Oct. 13, 2014 - GlobeNewswire
Chimerix's Brincidofovir Shows Potential Survival Benefit in Adenovirus Infection 6:30 a.m. Oct. 8, 2014 - GlobeNewswire
Chimerix Announces Emergency Investigational New Drug Applications for Brincidofovir Authorized by FDA for Patients With Ebola Virus Disease 8:02 a.m. Oct. 6, 2014 - GlobeNewswire
Data on Chimerix's Brincidofovir Suggests Favorable Resistance Profile in Adenovirus and Cytomegalovirus (CMV) 4:01 p.m. Sept. 8, 2014 - GlobeNewswire
Chimerix Appoints W. Garrett Nichols, MD, MS as Chief Medical Officer 8:02 a.m. Sept. 4, 2014 - GlobeNewswire
Chimerix's Brincidofovir Has in Vitro Activity Against Ebola 8:02 a.m. Sept. 3, 2014 - GlobeNewswire
Chimerix's Brincidofovir Selected for Two Oral Presentations Highlighting Resistance Data in CMV and Adenovirus at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 4:03 p.m. Sept. 2, 2014 - GlobeNewswire
Chimerix to Present at the Morgan Stanley Healthcare Conference 4:02 p.m. Sept. 2, 2014 - GlobeNewswire
Chimerix and BARDA Announce Continued Partnership in the Development of Brincidofovir for Smallpox 8:02 a.m. Sept. 2, 2014 - GlobeNewswire
Chimerix Announces Second Quarter 2014 Financial Results 7:02 a.m. Aug. 7, 2014 - GlobeNewswire
Chimerix to Announce Second Quarter Financial Results on August 7, 2014 5:20 p.m. July 31, 2014 - GlobeNewswire
New Data on Chimerix's Brincidofovir Supports Safety and Antiviral Activity Against Multiple Life-Threatening DNA Viruses in Organ Transplant Recipients 8:02 a.m. July 31, 2014 - GlobeNewswire
Chimerix Announces Three Abstracts to be Presented at the 2014 World Transplant Congress 4:01 p.m. July 8, 2014 - GlobeNewswire
Chimerix Mourns Passing of Director Rodman L. Drake 9:26 a.m. June 26, 2014 - GlobeNewswire
Clinical Trial Data, NDA Submissions, and Board Changes - Analyst Notes on Alkermes, Cubist, Repligen, Flamel Technologies and Chimerix 5:20 a.m. June 25, 2014 - PR Newswire - PRF
Chimerix Announces New Directors 8:01 a.m. June 23, 2014 - GlobeNewswire
Chimerix to Present at the JMP Securities Healthcare Conference 4:01 p.m. June 17, 2014 - GlobeNewswire
Chimerix Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock 4:02 p.m. May 27, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 225

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 242

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 135

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 222

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Bouygues Enhances Shareholder Value Through Buyback Actions

Updated Category News Views 74

Bouygues Boosts Shareholder Value with Buyback Initiatives In corporate finance, share buybacks are often adopted as a strategic way to strengthen shareholder trust and increase stock value. Recently, Bouygues SA's trading activities have shown their dedication to creating value and aligning with the interests of their shareholders. Summary of Recent Buyback Activities...

Continue Reading
Warren Buffett's Investment in Occidental Faces Major Setback

Updated Category News Views 61

Warren Buffett's Investment Challenges with Occidental Petroleum Recently, Occidental Petroleum's shares dropped by 29% since mid-April, which has a direct impact on Warren Buffett’s large investment in the company. This decline raises concerns about potential strategies for future investments. Investment Context and Current Situation Chris Bloomstran, an experienced...

Continue Reading
Datavault AI Boosts WiSA Technology for Enhanced Home Audio

Updated Category News Views 275

Enhancing Audio Experience with Datavault AI's Innovations In the ever-evolving world of audio technology, Datavault AI has made significant strides to enhance the home audio experience. Through its Acoustic Science Division's Wireless Sound Association (WiSA), the company has launched several cutting-edge solutions designed to elevate audio quality while maintaining...

Continue Reading
Turkey Central Bank's Recent Interest Rate Reduction Explained

Updated Category News Views 297

Turkey's Central Bank Interest Rate Adjustment The central bank of Turkey has recently made headlines by announcing a significant reduction in its interest rate for the second consecutive time. This move is primarily attributed to a more pronounced slowdown in inflation that has taken place recently. Rate Cut Details The Monetary Policy Committee, led by the governor, has...

Continue Reading
Embracing Inclusivity: The Proud Pair Jewelry Initiative

Updated Category News Views 350

Embracing Inclusivity: The Proud Pair Jewelry Initiative In a significant step towards inclusivity, Hong Kong Marriage Equality has joined forces with the innovative local jewellery brand Playback Concept to unveil the "Proud Pair" collection. This unique initiative reimagines traditional jewellery by incorporating essential motifs that resonate with diverse gender...

Continue Reading